CAPPED-BONUS-ZERTIFIKAT - FRESENIUS Share Price

Certificat

DE000SR7X4N1

Market Closed - Deutsche Boerse AG 08:25:19 17/05/2024 pm IST
60.41 EUR -2.66% Intraday chart for CAPPED-BONUS-ZERTIFIKAT - FRESENIUS
Current month+0.07%
1 month+5.23%
Date Price Change
17/24/17 60.41 -2.66%
16/24/16 62.06 +0.15%
15/24/15 61.97 -0.23%
14/24/14 62.11 +0.27%
13/24/13 61.94 +0.72%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 08:25 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SR7X4N
ISINDE000SR7X4N1
Date issued 11/06/2021
Strike 59.28
Maturity 11/06/2024 (25 Days)
Parity 0.45 : 1
Emission price 101
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 101
Lowest since issue 39.52

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.94 EUR
Average target price
36.41 EUR
Spread / Average Target
+30.30%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW